Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
THOUSAND OAKS, Calif., June 6, 2013 /PRNewswire/ -- Amgen (AMGN) will present at the Goldman Sachs 34th AnnualGlobal Healthcare Conference on Tuesday, June 11, 2013, at the Terranea Resort, Rancho Palos Verdes, Calif., beginning at 11:20 a.m. PDT. Jonathan M. Peacock, executive vice president and chief financial officer at Amgen, and Anthony C. Hooper, executive vice president of Global Commercial Operations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)